Correlation Between Summit Hotel and Eupraxia Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Summit Hotel and Eupraxia Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Summit Hotel and Eupraxia Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Summit Hotel Properties and Eupraxia Pharmaceuticals Common, you can compare the effects of market volatilities on Summit Hotel and Eupraxia Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Summit Hotel with a short position of Eupraxia Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Summit Hotel and Eupraxia Pharmaceuticals.
Diversification Opportunities for Summit Hotel and Eupraxia Pharmaceuticals
-0.74 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Summit and Eupraxia is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding Summit Hotel Properties and Eupraxia Pharmaceuticals Commo in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eupraxia Pharmaceuticals and Summit Hotel is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Summit Hotel Properties are associated (or correlated) with Eupraxia Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eupraxia Pharmaceuticals has no effect on the direction of Summit Hotel i.e., Summit Hotel and Eupraxia Pharmaceuticals go up and down completely randomly.
Pair Corralation between Summit Hotel and Eupraxia Pharmaceuticals
Considering the 90-day investment horizon Summit Hotel Properties is expected to under-perform the Eupraxia Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Summit Hotel Properties is 1.96 times less risky than Eupraxia Pharmaceuticals. The stock trades about -0.14 of its potential returns per unit of risk. The Eupraxia Pharmaceuticals Common is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest 309.00 in Eupraxia Pharmaceuticals Common on December 21, 2024 and sell it today you would earn a total of 82.00 from holding Eupraxia Pharmaceuticals Common or generate 26.54% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 98.33% |
Values | Daily Returns |
Summit Hotel Properties vs. Eupraxia Pharmaceuticals Commo
Performance |
Timeline |
Summit Hotel Properties |
Eupraxia Pharmaceuticals |
Summit Hotel and Eupraxia Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Summit Hotel and Eupraxia Pharmaceuticals
The main advantage of trading using opposite Summit Hotel and Eupraxia Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Summit Hotel position performs unexpectedly, Eupraxia Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eupraxia Pharmaceuticals will offset losses from the drop in Eupraxia Pharmaceuticals' long position.Summit Hotel vs. Diamondrock Hospitality | Summit Hotel vs. RLJ Lodging Trust | Summit Hotel vs. Pebblebrook Hotel Trust | Summit Hotel vs. Sunstone Hotel Investors |
Eupraxia Pharmaceuticals vs. Chemours Co | Eupraxia Pharmaceuticals vs. Eastman Chemical | Eupraxia Pharmaceuticals vs. Ferrari NV | Eupraxia Pharmaceuticals vs. NL Industries |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |